focus -WSS

focus

author：knowledge 2025-10-01 11:32:58 - browse：241

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Stanford president to resign after investigation of research

WSS

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Plane’s emergency slide plummets from sky, hits Chicago home

Stanford updates investigation of president’s past research

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Wikipedia

focus

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Norman Reedus' Daryl Dixon

The cancer drug shortage isn’t new — and neither are the solutions

Why some people catch Covid but never get sick

In age of alternative facts, a scholarly course on calling out crap

'Reaching a detente': STAT's Helen Branswell on covering Covid

In Memoriam: Notable people who died in 2023

Why the Crimean Bridge is key to Russia's war in Ukraine

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Poor hospice wound care hurts patients and families

hotspot

New warning issued for rebooking air travel after delays, cancellations

David Sabatini, ex

Surge of respiratory disease in China has likely explanation

The kidney, in all its complexity, is captured in a new atlas

Stanford president to resign after investigation of research

Plane’s emergency slide plummets from sky, hits Chicago home

entertainment

knowledge

explore

hotspot